Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Getinge

195.80 SEK

-0.38 %

Less than 1K followers

GETI B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Getinge

2019202020212022202320242025
Revenue26,559.029,819.027,049.028,292.031,827.034,759.034,969.0
growth-%12.3 %-9.3 %4.6 %12.5 %9.2 %0.6 %
EBITDA4,595.07,251.06,185.05,653.05,829.05,275.06,039.0
EBIT2,372.04,784.04,371.03,626.03,736.02,854.03,789.0
Profit before taxes1,909.04,485.04,188.03,472.03,343.02,282.03,145.0
Net income1,256.03,273.03,000.02,516.02,428.01,654.02,276.0
EPS4.4911.8910.909.158.866.018.29
Dividend1.503.004.004.254.404.604.75
Dividend ratio33.4 %25.2 %36.7 %46.4 %49.7 %76.5 %57.3 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%17.3 %24.3 %22.9 %20.0 %18.3 %15.2 %17.3 %
EBIT-%8.9 %16.0 %16.2 %12.8 %11.7 %8.2 %10.8 %
ROE6.0 %15.2 %11.9 %8.3 %8.0 %5.0 %7.7 %
ROI2.8 %7.3 %6.7 %4.8 %4.5 %2.6 %4.0 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.